Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9018201

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in trea

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9012647

Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treat

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9011913

Use of functionalized magnetic nanoparticles in cancer detection and treatment

The Regents of the University of California · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9005599

Genetically modified human umbilical cord perivascular cells for prophylaxis against or tr

Tissue Regeneration Therapeutics Inc. · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8999934

Treatment of astrocytes-tumor cells inhibitors of endothelin receptors

The Board of Regents of the University of Texas System · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8999638

Method of treatment based on polymorphisms of the KCNQ1 gene

VANDA PHARMACEUTICALS INC. · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993633

Treatment of muscle disease characterized by insulin resistance

Fate Therapeutics, (Canada) Inc. · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993627

N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated

SENTIENT LIFESCIENCES, INC. · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993626

Methods of treatment using sterculic acid

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993552

Compositions and methods for treatment of leukemia

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993519

Method of treatment for neutropenia using stable formulations of recombinant human albumin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987308

Compounds for the treatment of Clostridium difficile-associated disease

Summit Corporation Plc · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8987228

Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-id

CAN-FITE BIOPHARMA LTD. · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8986737

Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of b

The Board of Regents of the University of Texas System · Granted Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8980871

Methods of treatment for hemolysis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8980549

MicroRNA patterns for the diagnosis, prognosis and treatment of melanoma

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8975243

Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal trac

The Regents of the University of California · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8974363

Topical medicaments and methods for photodynamic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8969409

Treatment for pulmonary hypertension

United Therapeutics Corporation · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8968729

Date pit composition for the treatment of animals

UNITED ARAB EMIRATES UNIVERSITY · Granted Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962824

Composition of novel carbohydrate drug for treatment of human diseases

GALECTIN THERAPEUTICS, INC. · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962593

GLA monotherapy for use in cancer treatment

IMMUNE DESIGN CORP. · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8962561

Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-rel

The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center · Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8957047

GLA monotherapy for use in cancer treatment

IMMUNE DESIGN CORP. · Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted